Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

PHARMA

The future of pharma is open source

The best pharmaceutical companies use Posit and open source to bring life-changing drugs to market faster. We support teams with world-class tooling (built specifically for Life Sciences) and unmatched industry expertise, helping pharmaceutical companies make better decisions, work through clinical trials faster, and submit to the FDA more confidently. All with the power of open source.
Get started with Posit

The top 20 pharma companies in the world use Posit

Janssen, Pharmaceutical Company of Johnson & Johnson - Logo Roche Logo Pfizer Logo GSK logo AstraZeneca logo Lilly logo

We help bring life-changing medicines to market — faster, safer, and with greater efficiency

Talk with a pharma expert
Long-term partnerships with industry leaders

We are committed to sustaining the open-source data science and scientific research ecosystem through healthy vendor relationships. That's why 100% of the top 20 pharmaceutical companies trust Posit for drug discovery and development.

Free and open-source tools, specifically for pharma

We work with the industry's top data science teams to develop, maintain, and advance the Pharmaverse, a package ecosystem built specifically for clinical workflows.

security checkmark
Enterprise solutions for drug discovery and development

No one knows more about open source in the enterprise than us. Posit's enterprise toolchain serves as a foundational component for Statistical Computing Environments across the industry, ensuring reproducibility, scalability, and security.

Roche Logo
Open source in drug development, with Phil Bowsher and Thomas Neitmann
Roche Senior Data Scientist Thomas Neitmann is a leader in the Pharmaceutical industry and a champion of open-source in late-stage clinical trials. In a recent interview with Phil Bowsher, Director of Life Sciences and Healthcare at Posit, Thomas discusses the Roche open-source initiative, the creation of influential packages such as Admiral, reproducibility and validation in clinical work, and regulatory submissions in R.

“We cannot influence whether or not a study reads out positively in the end. But if it does, that basically means it's time for that submission, which uses R and Open Source as its backbone, to get submitted to the Health Authority. And actually, there's one Phase Three trial we have in Oncology which is already on the R platform.”

Thomas Neitmann

Senior Data Scientist at Roche

Posit partners with the world's largest pharma companies to build packages for clinical reporting

Package dependencies maintained by Posit engineers:

ROCHE | GSK

61%

Janssen

45%

ValidationHub

56%

ROCHE | Novartis

51%

Why Posit for drug discovery and development

Make go/no-go decisions faster

Open source makes innovation the standard at every go/no-go checkpoint, shortening the feedback loop on decisions in clinical trials by months. Use Shiny applications to analyze clinical trial data in interactive ways. Feed dashboards that display the status of trials in real-time. Leverage packages designed specifically for pharma to streamline clinical workflows. Open source gets you from thousands of compounds to one leading molecule faster than ever.

Let us help you with clinical trials
Manipulate data more efficiently

Every clinical trial produces hundreds of outputs. Pharmaceutical companies are partnering to build and use packages that help programmers automate this process. Open source can get you to SDTM/ADaM datasets quicker. And once you have SDTM/ADaM datasets, use open source for better validation and quality control.

Let us help you with packages designed for pharma
Submit to the FDA confidently

Open source can and should be used in regulatory submissions. Leading pharmaceutical companies are collaborating with regulatory agencies like the FDA more than ever before, providing guidance and obtaining feedback on how open source should be used for submissions.

Let us help you with regulatory submissions

Real impact, made possible by only open source and Posit

Life Sciences companies of all kinds—pharmaceutical, healthcare, and biotechnology—are turning raw data into artifacts that convey information like never before, all with the power of Posit and open-source tools like Shiny. Look at the sample gallery below to see how open source contributes to a healthier, safer world.
See Gallery

Milestone prediction tool

MAYO CLINIC

An app used to predict a milestone time (time to a specific number of events) for clinical trial monitoring.

Learn more

Clinical Trial Eligibility Estimator

MAYO CLINIC

An app that shows clinical trial eligibility for Diffuse Large B-cell Lymphoma patients.

Learn more

Posit Team

Our end-to-end platform

An all-in-one solution for teams who use R and Python
The world's leading pharmaceutical companies leverage open-source with Posit Team, a complete toolchain that drives innovation in clinical operations. Build and host Shiny applications and dashboards that give decision makers access to real-time, interactive clinical data, accelerating critical go/no-go decisions. Snapshot and restore versions of packages to maximize the reproducibility of clinical trial analyses.
Learn more about Posit Team

Posit tools support the leading packages in clinical reporting

View All
Tables

tidy tlg
tfrmt
tplyr
pharmartf
rtables

Package
validation

riskmetric
riskassessment
altools
covtracer

SDTM / ADaM

sdtmchecks
datacutr
admiral

Plots

visR
ggsurvfit

Frameworks

TERN
TEAL

Utility

logrx
envsetup

Metadata

METATOOLS
metacore

eSub

pkglite
xportr

Interactive

tidyCDISC

portrait of James Black in front of blue background

"There are multiple drivers behind our shift to open-source languages and tools. Data Scientists graduating today expect R and Python to be the backbone of our tools, and our internal experienced data scientists realize and are excited by the new tools and innovations available from this shift."

James Black

Senior Director of Insights Engineering, Roche

portrait of Gabriella Rustici

"Experiential learnings is key to generating the motivation needed to develop our Data Scientists, and RStudio Academy has been a great ally in this journey."

Gabriella Rustici

Director of Data Science Learning and Development, AstraZeneca

portrait of Mike Smith in the pharma industry

"Posit products allow us to deploy R more easily, get started quicker, have confidence that the tools and packages we’re using are accessible and reproducible in the long term, and that we can develop and deploy modern data science products within our company, allowing us to concentrate on better science, faster decision making and getting our medicines to patients more quickly."

Mike Smith

Senior Director of Statistics, Pfizer

We're experts at helping leading pharmaceutical companies implement open-source into complex clinical workflows.

Let us help you understand the tools you should be using and the skills you need to teach your workforce, so you can bring drugs to market quicker and more confidently.

Book a call with our experts